Navigation Links
2009 H1N1 Flu Test From Quest Diagnostics Now CE Marked For International Distribution Under The Simplexa(TM) Brand Name
Date:11/17/2009

MADISON, N.J., Nov. 18 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that the Simplexa Influenza A H1N1 (2009) test developed by its Focus Diagnostics business has been CE marked and is now available as a test kit for distribution to approximately 35 countries in Europe. Focus Diagnostics is showcasing the test at MEDICA 2009, November 18 to 21, 2009, at the Dusseldorf Fair Trade Centre, Hall 3, Stand D20, Booth 2 (American Pavilion).

"As the influenza A(H1N1) 2009 virus continues to spread across the globe, it is imperative that clinicians have access to reliable tests for quickly and definitively identifying infected patients," said Harald Kessler, M.D., professor and head of the research unit "Molecular Diagnostics", Medical University of Graz, Austria. "The new Simplexa assay may contribute to a fast and reliable option for generating 2009 H1N1 virus test results in molecular laboratories throughout Europe and many other regions. Fast turnaround time can aid in clinical management of patients and allow hospitals to segregate infected patients from other high-risk individuals."

The Focus Diagnostics Simplexa(TM) Influenza A H1N1 (2009) test employs real-time reverse transcription polymerase chain reaction (RT-PCR) to qualitatively detect the 2009 H1N1 flu virus in a patient's nasal or nasopharyngeal specimens. The test targets a region of the hemagglutinin gene of the 2009 H1N1 influenza virus specifically to detect the presence of 2009 H1N1 influenza RNA, thereby differentiating it from seasonal human influenza A viruses. The World Health Organization (WHO), which provides guidance for countries managing the pandemic, states that RT-PCR is the "only rapid diagnostic test for which a positive resul
'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Quest Diagnostics Announces Pricing of Tender Offer for Any and All of Certain of its Outstanding Notes
2. FDA Grants GeoVax Labs, Inc. Request For Pre-IND Meeting
3. Quest Diagnostics Commences Cash Tender Offer for Any and All of Certain of its Outstanding Notes
4. Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering
5. Quest Diagnostics To Speak At The Oppenheimer 20th Annual Healthcare Conference
6. For the First Time, Blood Donors May Answer Their Health History Questions Online From the Privacy of Their Home or Office
7. FDA Issues Another Emergency Use Authorization for Commercial H1N1 Flu Test to Quest Diagnostics Focus Diagnostics
8. Dynatronics Will Request Hearing With Nasdaq Regarding Listing Status
9. Quest Diagnostics Brings Genetic Testing for Plavix(R) Response to Coronary Stent Patients at Scripps Health
10. Stemedica Requests Pre-IND Meeting With FDA
11. NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... February 9 Hoya,announces the appointment of Mr. ... Care,Europe starting the 1st of April 2010 . He ... been leading the European branch in the past 5 years. ... Mr. Werquin has 20 years experience ... Belgium and Hoya Lens France. Based in, Paris , he ...
(Date:2/8/2010)... Feb. 8 Rapid developments in ... increase in the use and cost of "specialty" ... and psoriasis. This has led to some inappropriate ... and medication coverage being spread over both pharmacy ... solution with Medication Cost Integration (MCI), which covers ...
(Date:2/8/2010)... Md. , Feb. 8 Hanger Orthopedic ... it plans to report its results of operations for the ... February 10, 2010 . ,, The Company plans to issue ... December 31, 2009 on Wednesday, February 10, ... call is scheduled to begin at 9:00 a.m., EST ...
Breaking Medicine Technology:New CEO for Hoya Vision Care Europe 2RegenceRx Leads the Industry With Introduction of Medication Cost Integration 2RegenceRx Leads the Industry With Introduction of Medication Cost Integration 3Hanger Orthopedic Group, Inc. Announces 2009 Year-End Earnings Release Conference Call 2LCA Vision Reports on Annual Meeting of Stockholders 47638 1LCA Vision Reports on Annual Meeting of Stockholders 47638 2LCA Vision Reports on Annual Meeting of Stockholders 47638 3LCA Vision Reports on Annual Meeting of Stockholders 47638 4Hispanic Dental Association and Oral Health America Celebrate National Smile Month June 1 30 47633 1Hispanic Dental Association and Oral Health America Celebrate National Smile Month June 1 30 47633 2New One Year Data from REMICADE 28R 29 SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohns Disease 4518 1New One Year Data from REMICADE 28R 29 SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohns Disease 4518 2New One Year Data from REMICADE 28R 29 SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohns Disease 4518 3New One Year Data from REMICADE 28R 29 SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohns Disease 4518 4New One Year Data from REMICADE 28R 29 SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohns Disease 4518 5New One Year Data from REMICADE 28R 29 SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohns Disease 4518 6New One Year Data from REMICADE 28R 29 SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohns Disease 4518 7New One Year Data from REMICADE 28R 29 SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohns Disease 4518 8New One Year Data from REMICADE 28R 29 SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohns Disease 4518 9
... clinical program to further evaluate the benefits of Dimebon in ... (NYSE: PFE ) and Medivation, Inc. (Nasdaq: ... a 12-month, Phase 3 clinical trial of the investigational drug ... evaluate the safety and efficacy of Dimebon when added to ...
... April 14 Oasmia,Pharmaceutical, Uppsala, Sweden, has been ... Paclical(R) for the treatment of ovarian cancer. Orphan ... expedite and,optimize drug development and upon approval a ... (Logo: http://www.newscom.com/cgi-bin/prnh/20070918/273312 ) , ...
Other Medicine Technology:Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimer's Disease 2Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimer's Disease 3Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimer's Disease 4Oasmia: FDA Grants Paclical(R) Orphan Drug Designation for Ovarian Cancer in the USA 2
(Date:2/9/2010)... thinking skills, , , TUESDAY, Feb. 9 (HealthDay News) ... and memory skills in people with Huntington,s disease, ... Huntington,s affects movement, behavior and cognitive abilities, and ... to 30 years of its onset. Cognitive problems ... Huntington,s progresses, leading to the inability to work ...
(Date:2/9/2010)... ARLINGTON, Va. , Feb. 9 /PRNewswire-USNewswire/ ... Education (NASBE), a longtime leader in the fight ... First Lady Michele Obama as she ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20091016/DC90501LOGO ) ,, "We are ... First Lady. The visibility and resources it brings ...
(Date:2/9/2010)... Obesity ,, A t tr i bu ... er l ing K. Spe i rn, pres ... of t he W.K. Ke l ... Feb. 9 The W.K. Kellogg Foundation deeply supports the ... against childhood obesity. We,re excited about her personal passion for this work and ...
(Date:2/9/2010)... The Providence Service Corporation, one of ... today announced that it plans to relocate its corporate ... , working with Peach Properties, will take over the ... adjacent to the new site of Tucson Electric Power,s ... Tucson ,s public companies side by side and should ...
(Date:2/9/2010)... Speech Recognition and Stimulus Resource Library featured on redesigned MxSecure, ... ... Scottsdale, AZ (PR WEB) February 9, 2010 -- ... to announce the launch of their new website., , , ... headline on MxSecure,s revamped website, and it captures the focus ...
Breaking Medicine News(10 mins):Health News:Drug May Ease Cognitive Effects of Huntington's 2Health News:NASBE Supports First Lady Michelle Obama in Fight Against Childhood Obesity 2Health News:NASBE Supports First Lady Michelle Obama in Fight Against Childhood Obesity 3Health News:Changing the Course of Kid's Health 2Health News:Changing the Course of Kid's Health 3Health News:Changing the Course of Kid's Health 4Health News:Changing the Course of Kid's Health 5Health News:Providence Service Corporation Relocates Corporate Headquarters to Downtown Tucson 2Health News:Providence Service Corporation Relocates Corporate Headquarters to Downtown Tucson 3Health News:Medical Transcription Services and EHR Provider MxSecure Launches New Enhanced Website with Goal of Improved Physician Productivity 2
... May 4 Haemonetics Corporation (NYSE: HAE ... and its eighth consecutive quarter of double digit revenue growth. ... $598 million, up 16%; operating income of $86 million, up ... per share of $2.27, up 17%. The Company also ...
... guests include State Rep. Brian Bosma as Master of Ceremonies, ... honor of Better Hearing and Speech Month , Hear ... presented by Peyton Manning Children,s Hospital at St. Vincent. ... the tenth anniversary of Newborn Hearing Screening in Indiana. Same-day ...
... Appeals Delisting Decision to Nasdaq Listing and Hearing Review ... Inc. (Nasdaq: ADLS ) announced today that ... to suspend trading in the Company,s common stock from ... business on Tuesday, May 5, 2009. The Panel,s ...
... Presented at Society of American Gastroenterological and Endoscopic ... USGI Medical, Inc. (USGI), announced that its ... podium sessions at the 2009 Society of American ... Postgraduate Course, held in Phoenix, Arizona.Dr. Frank Borao ...
... Leading Producer of Online, Educational Resources Aims to Empower ... /health/diseasesinjuriesandconditions/swineflu/ , , NEW YORK, May 4 ... from children across the country, BrainPOP ... for grades 3 and up -- has launched a ...
... FY 2010 Proposed Medicare Cut Weakens Key Health Care ... Mo., May 4 The Coalition to Protect Senior ... a Medicare regulation put forward for implementation Friday by ... proposed Medicare rule, a Coalition spokeswoman said, would cut ...
Other Medicine News:Health News:Haemonetics Shares Success of Outstanding Fiscal 2009 Performance with Employees 2Health News:Hear Indiana holds 6th Annual Talk Walk Run at Fort Harrison State Park to Celebrate Deaf Children Who Listen and Speak 2Health News:Hear Indiana holds 6th Annual Talk Walk Run at Fort Harrison State Park to Celebrate Deaf Children Who Listen and Speak 3Health News:Advanced Life Sciences Announces Delisting From Nasdaq and Pending Quotation of its Common Stock on the OTC Bulletin Board 2Health News:Studies Report Use of USGI Medical's Incisionless Operating Platform(TM) (IOP) in Numerous Incisionless Surgical Procedures 2Health News:Studies Report Use of USGI Medical's Incisionless Operating Platform(TM) (IOP) in Numerous Incisionless Surgical Procedures 3Health News:Free New Content From BrainPOP Helps Explain Swine Flu to Kids 2Health News:Nation's Front Line Caregivers Mobilizing to Help Defeat Obama Implementation of Damaging Medicare Regulation 2
Ten-Ten duodecapolar diagnostic mapping catheters are available in four curve sizes....
... six electrodes which are spaced to permit ... Positioned in the Right Atrium, the catheter ... The catheter may then be repositioned to ... and ventricular pacing and recording. If indicated, ...
Standard Deflectable Catheters...
... Inquiry H Steerable Catheter. Steerable ... variety of designs and a ... stability. 10 to 24 electrodes, ... inactive and active tip electrodes, ...
Medicine Products: